CTRI/2021/11/038154已完成不适用
To evaluate the Anti-grey efficacy of test regimen in healthy Indian human
Unilever Industries Pvt Ltd1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2021年10月25日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 180
- 试验地点
- 1
- 主要终点
- Significant improvement in Grey hair condition by expert/dermatologist assessment
研究概览
简要总结
Study will be conducted to assess the efficacy of test product in imparting Grey hair benefits. After consenting and qualifying the inclusion and exclusion criteria subjects will be enrolled into the study. Post baseline assessments, test product will be dispensed to subjects as per randomization and subjects will be instructed to use the product thrice a week and evaluation assessments will be done at different times points over a period of 5 months.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Participant and Investigator Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 42.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Female and male subjects in the ratio of 2:1 in general good health.
- •2.Subjects in the age group 18-42 years (both the ages inclusive).
- •3.Subjects willing to give a written informed consent and agree to come for a regular follow up visit.
- •4.Subjects willing to apply TP as per instruction and they will not use any other hair product during the study period 5.Subjects willing to abide by and comply with the study protocol.
- •6.Subjects who have not participated in a similar investigation in the past three months.
- •7.Subjects who agree to refrain from using hair dye / hair colour /henna during the study period.
- •8.Subjects willing to refrain from any type of hair treatment like perming, straightening etc.
- •during the study duration.
排除标准
- •1.Subjects who have undergone hair growth treatment within 3 months before screening into the study.
- •2.Subject who are currently using henna.
- •3.Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.
- •4.Subjects (females) who are pregnant or lactating 5.Subjects who have had hair transplant.
- •6.A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.
- •7.Chronic illness which may influence the cutaneous state.
- •8.Subjects participating in other similar cosmetic or therapeutic trial within last three months 9.Subjects who have history of alcoholism, smoking and/ or psychiatric disorder including trichotillomania.
- •10.Menopausal female subjects as determined by medical history 11.Any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.
- •12.Subjects having allergic reaction for oil.
结局指标
主要结局
Significant improvement in Grey hair condition by expert/dermatologist assessment
时间窗: 4 Months product and 1 Month regression
次要结局
- Significant reduction and prevention in reoccurence of Grey hair condition by expert/dermatologist assessment(4 Months product and 1 Month regression)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Anti-Grey hair studyCTRI/2021/11/038154nilever Industries Pvt Ltd159
已完成
2 期
Hair Benefit Study For The Ayurvedic Proprietary MedicineCTRI/2023/06/053922Hindustan Unilever Ltd225
已完成
不适用
Hair Benefit Study For The Test ProductsCTRI/2021/09/036928Unilever Industries Pvt Ltd220
已完成
不适用
Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen EffluviumHealthyTelogen EffluviumNCT06545552Activ'inside66
已完成
不适用
ANTIPIGMENTING OR DEPIMENTING EFFICACY UNDER PART OF VISIBLE LIGHTNCT06945393L'Oreal30